Hepatitis C virus infection in chronic haemodialysis patients - Relationship to blood transfusions and dialyser re-use

South African Medical Journal

Volumn 90, Issue 6, 2000, Pages 621-625

  Taal, M W ^a,b   Van Zyl Smit, R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; POLYSULFONE;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SCREENING; TIME; VIRUS TRANSMISSION;

ADULT; BLOOD TRANSFUSION; CROSS INFECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0034051335     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Knudsen F, Wantzin P, Rasmussen K, et al. Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993; 43: 1353-1356.
2. Huraib S, al-Rashed R, Aldrees A, Aljefry M, Arif M, al-Faleh FA. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995; 10: 470-474.
3. Fabrizi F, Lunghi G, Guarnori I, et al. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study. Nephrol Dial Transplant 1994; 9: 1611-1615.
4. Fujiyama S, Kawano S, Sato S, et al. Prevalence of hepatitis C virus antibodies in haemodialysis patients and dialysis staff. Hepatogastroenterology 1992; 39: 161-165.
5. Dussol B, Berthezene P, Brunei P, Roubicek C, Berland Y. Hepatitis C virus infection among chronic dialysis patients in the south of France: A collaborative study. Am J Kidney Dis 1995; 25: 399-404.
6. Oliva JA, Maymo RM, Carrio J, Delgado O, Mallafre JM. Late seroconversion of C virus markers in hemodialysis patients. Kidney Int 1993; 43: Suppl 41, S-153-S-156.
7. Brugnano R, Franscisci D, Quintaliani G, et al. Antibodies against hepatitis C virus in haemodialysis patients in the central Italian region of Umbria: Evaluation of some risk factors. Nephron 1992; 61: 263-265.
8. Cantu P, Mangano S, Masini M, Limido A, Crovetti G, DeFilippo C. Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 1992; 61: 337-338.
9. Zhang HY, Kuramoto IK, Mamish D, Sazama K, Holland PV, Zeldis JB. Hepatitis C virus in blood samples from volunteer donors. J Clin Microbiol 1992; 31: 606-609.
10. Janot C, Courouce AM, Maniez M. Antibodies to hepatitis C virus in French blood donors (Letter). Lancet 1989; 2: 294-297.
11. Chiaramonte M, Stroffolini T, Caporaso N, et al. Hepatitis C virus infection in Italy: a multicentric sero-epidemiological study. Ital J Gastroenterol Hepatol 1991; 23: 555-558.
12. Jadoul M, Cornu C Van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 1993; 44: 1322-1326.
13. Chauveau P, Courouce A-M, Lemarec N, et al. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Kidney Int 1993; 43: suppl 41, S-149-S-152.
14. Muller GY, Zabaleta M, Arminio A, et al. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992; 41: 1055-1058.
15. Mondelli MU, Cristina G, Piazza V, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in haemodialysis units using a second generation assay. Nephron 1992; 61: 350-351.
16. Vandelli L, Medici G, Savazzi AM, et al. Behaviour of antibody profile against hepatitis C virus in patients on maintenance hemodialysis. Nephron 1992; 61: 260-262.
17. Yamaguchi K, Nishimura Y, Fukuoka N, et al. Hepatitis C virus antibodies in haemodialysis patients (Letter). Lancet 1990; 335: 1409-1410.
18. Roth D, Fernandez JA, Babischkin S, et al. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease. Ann Intern Med 1992; 117: 470-175.
19. Pereira BJG, Milford EL, Kirkman RL, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327: 910-915.
20. Cassidy MJD, Jankelson D, Becker M, Dunne T, Walzl G, Moosa MR. The prevalence of antibodies to hepatitis C virus at two haemodialysis units in South Africa. S Afr Med J 1995; 85: 996-998.
21. Tucker TJ, Voigt M, Bird A, et al. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape - comparison of screening tests and PCR. S Afr Med J 1997; 87: 603-605.
22. Simon N, Courouce A-M, Lemarrec N, Trepo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46: 504-511.
23. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992; 19: 345-352.
24. Garcia-Valdecasas J, Carcia F, Cabezas T, Espigares MJ, Gallardo A, Cerezo S. Transmission of HCV infection in haemodialysis units; efficacy of a preventative protocol throughout five years. 13th International Congress of Nephrology, Madrid, Spain, 2-6 July 1995: 521.
25. Traver JA, Barril G. Evidence of other than blood transfusions as risk factors in the transmission of HCV in hemodialysis patients. 13th International Congress of Nephrology, Madrid, Spain, 2-6 July 1995.
26. Chiapelli H, Gadola L, Verdaguer C Russi J, Caorsi H, Varela A. Hepatitis C virus in blood ultrafiltrate in new and reused fibre (dialyzer), 13th International Congress of Nephrology, Madrid, Spain, 2-6 July 1995.
27. Flichman D, Amore A, Bonaudo R, et al. HCV-RNA was undetectable in repeated analyses of dialysis ultrafiltrates. 13th International Congress of Nephrology, Madrid, Spain, 2-6 July 1995.
28. Manzini P, Amore A, Brunetto MR, et al. Is hepatitis C virus detectable in dialysis ultrafiltrate? (Letter). Nephron 1996; 72: 102-103.
29. Valtuille R, Berridi J, Moretto H, et al. May passage across dialysis membrane transmit hepatitis C virus in hemodialysis units? 13th International Congress of Nephrology, Madrid, Spain, 2-6 July 1995.
30. Chan TM, Lok ASF, Cheng IKP, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5-8.
31. Pol S, Romeo R, Zins B, et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 1993; 44: 1097-1100.